Catalyst Wire Dossier Catalyst Wire Dossier

naproxen sodium/acetaminophen

naproxen sodium and acetaminophen · Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for naproxen sodium/acetaminophen, covering 2022-12-05 to 2022-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Naproxen Sodium/Acetaminophen Proof of Concept Dosing Study [Phase 2]

See pricing